Eton Pharmaceuticals (ETON) Amortizatization of Intangibles (2020 - 2025)

Eton Pharmaceuticals has disclosed Amortizatization of Intangibles across 6 years of filings, most recently posting -$477000.0 for Q4 2025.

• Amortizatization of Intangibles for Q4 2025 came in at -$477000.0, down 145.17% year-over-year; the trailing twelve-month figure through Dec 2025 was -$258000.0 (down 123.02% YoY), and the FY2025 annual result was $44000.0, down 37.14% from the prior year.
• Amortizatization of Intangibles came in at -$477000.0 for Q4 2025 at Eton Pharmaceuticals, down from $189000.0 in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $1.1 million in Q4 2024 to a low of -$477000.0 in Q4 2025.
• The 5-year median for Amortizatization of Intangibles is $30500.0 (2022), against an average of $63250.0.
• Across the five-year window, Amortizatization of Intangibles tumbled 174.19% in 2023 and surged 4691.3% in 2024, its largest moves.
• Eton Pharmaceuticals' Amortizatization of Intangibles stood at $38000.0 in 2021, then retreated by 18.42% to $31000.0 in 2022, then plunged by 174.19% to -$23000.0 in 2023, then soared by 4691.3% to $1.1 million in 2024, then sank by 145.17% to -$477000.0 in 2025.
• The last three Amortizatization of Intangibles figures came in at -$477000.0 (Q4 2025), $189000.0 (Q3 2025), and $13000.0 (Q2 2025), per Business Quant data.